<http://webisa.webdatacommons.org/398186419>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/398186419>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<lww.com> .
<http://webisa.webdatacommons.org/398186419>	<http://www.w3.org/ns/prov#value>	"However, there remain questions to be addressed, including the risk of inducing an R5 to X4 switch, the risk of lowering some specific immune responses, the interactions with other antiretroviral agents, and long-term tolerability." .
<http://webisa.webdatacommons.org/prov/457071906>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/398186419> .